Page last updated: 2024-10-27

flurbiprofen and Shock

flurbiprofen has been researched along with Shock in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wilkerson, RD1

Other Studies

1 other study available for flurbiprofen and Shock

ArticleYear
Possible role for prostaglandins in the production of alterations in pulmonary function during splanchnic arterial occlusion shock.
    The Journal of pharmacology and experimental therapeutics, 1977, Volume: 201, Issue:3

    Topics: Airway Resistance; Animals; Dogs; Female; Flurbiprofen; Lung; Lung Compliance; Male; Prostaglandins

1977